Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02360215
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:53.499101+00:00
Published At
2020-03-06T00:00:00+00:00
Record Updated At
2025-04-23
Results Posted At
2020-03-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cognitive Impairment", "Metastatic Malignant Neoplasm in the Brain", "Solid Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-23"
protocolSection.identificationModule.nctId
"NCT02360215"
protocolSection.identificationModule.officialTitle
"A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-03-06"

Study condition terms

  • Cognitive Impairment (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Neoplasm in the Brain (protocolSection.conditionsModule.conditions)
  • Solid Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.